With the advent of neural implants and novel therapies, the cure of multiple neurodegenerative disorders proves wholesome for the patients’ suffering. Increasing in the severity of neurodegenerative diseases, demands the discovery of new translational approaches in neuroscience research.
MarketsandMarkets 6th Annual Neuroscience R&D conference to be held on 9th - 10th October 2023 in London, UK aims to offer a wide space to the experts from academia and industry together to discuss novel therapeutics, emerging trends, major challenges, and interesting revolutions that could be blooming in neuroscience in near future. The conference will be centred on focusing on the most recent advancements in preclinical, translational neuroscience research while also bringing the audience's attention to the emerging role of AI and big data in neuroscience R&D space. This two-day programme will feature expert keynote presentations, cutting-edge discussions, and live case studies, giving stakeholders the chance to participate in this scientific meeting and network with industry peers while staying up to date on the most recent advancements in neuroscience research.
CSO, Talisman therapeutics
, The ALS Association
, Eli Lilly Company
Data Scientist, Neuroimaging Researcher, Dementia Platform UK
Chief Executive Officer, Elixa MediScience, UK
Chief Medical Officer, Exciva Gmbh, UK
Head of Department of Neurosciences, University of Sheffield, UK
Assistant Professor in Translational Neuroscience, University of Nottingham
Professor in Neuroprosthetics, Newcastle University
Senior VP and Therapeutic Area Head, Roche
Assistant Professor, University of Twente